Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 6/20 | 0.37 |
| ▸ | HTR1A | P08908 | 3/20 | 0.35 |
| ▸ | HTR7 | P34969 | 3/20 | 0.35 |
| ▸ | PCK1 | P35558 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | SLC8A1 | P32418 | 1/20 | 0.32 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.32 |
| ▸ | PDE5A | O76074 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309867 | 1.00 | SCN9A (0.37) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL29566912 | 0.91 | HTR1A (0.35) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL26808948 | 0.91 | HTR1A (0.35) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL29567274 | 0.88 | SCN9A (0.36) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL24309559 | 0.88 | SCN9A (0.36) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL29567870 | 0.87 | HTR1A (0.37) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL24310731 | 0.87 | HTR1A (0.37) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL24309548 | 0.84 | SCN9A (0.34) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL29566769 | 0.84 | SCN9A (0.34) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL26808698 | 0.84 | HTR1A (0.36) | SCN9AHTR1AHTR7PCK1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225748-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |